Agenus | AGEN - Gross Profit On Sales


Agenus reported $33.74M in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
AbbVie USD 14.39B 1.85B Jun/2026
Agenus USD 33.74M 468K Mar/2026
Amgen USD 5.87B 1.02B Mar/2026
AstraZeneca USD 12.86B 251M Jun/2026
Bristol-Myers Squibb USD 9.26B 1.19B Jun/2026
Celldex Therapeutics USD 15K 106K Mar/2026
CSL USD 4.46B 2.71B Dec/2025
Eli Lilly USD 16.22B 301.7M Mar/2026
Gilead Sciences USD 6.8B 1.29B Jun/2026
GlaxoSmithKline GBP 6.51B 757M Jun/2026
Glaxosmithkline GBP 5.75B 2.99B Mar/2026
Incyte USD 1.57B 400.89M Jun/2026
Intrexon USD -297K 167K Jun/2024
J&J USD 18.55B 1.31B Jun/2026
Jiangsu Hengrui CNY 7.27B 918.27M Dec/2025
Karyopharm Therapeutics USD 33.72M 1.13M Mar/2026
MacroGenics USD 11.24M 19.87M Mar/2026
Merck EUR 3.17B 101M Jun/2026
Merck USD 12.09B 1.24B Mar/2026
Novartis USD 11.24B 1.18B Jun/2026
Novavax USD 125.04M 76.09M Dec/2025
Pfizer USD -248M 11.29B Jun/2026
Regeneron Pharmaceuticals USD 3.71B 778.2M Jun/2026
Rigel Pharmaceuticals USD 28.49M 7.01M Jun/2024
Sangamo BioSciences -2.39M 1.09M Jun/2024
Veracyte USD 108.55M 7.39M Jun/2026